Literature DB >> 33817433

Glutathione-related antioxidant defense system in patients with hypertensive retinopathy.

Pavlovschi Ecaterina1, Pantea Valeriana2, Borovic Djina3, Tagadiuc Olga1.   

Abstract

Objective: To analyze the glutathione antioxidant defense system changes in the tear and serum of patients with hypertensive retinopathy (HR) and to establish whether there is an interdependence between their levels and HR degree.
Methods: 90 patients were split into three groups according to the Keith-Wagner-Barker grading of HR: GI-36 patients; GII-35 patients; GIII-19 patients. The concentration of reduced glutathione (GSH) and activities of glutathione peroxidase (GPx) and glutathione reductase (GR) in tear and serum were measured. Results were analyzed by ANOVA, followed by Bonferroni post hoc test. The Spearman correlation coefficient was calculated (p≤0.05 statistically significant).
Results: In serum, the GSH level and GPx activity were not statistically changed between groups with HR degree advancement, unlike the GR activity that was statistically diminished (p=0.018). The values of the studied markers in the tear showed a decrease with the progression of the HR degree. Only serum GSH level correlated with the tear one (r=-0.361, p=0.000), while the enzymes activity did not. A correlation of GPx and GR activity (r=0.417, p=0.000) was identified in tear, while in serum - of GPx activity and GSH level (r=409, p=0.000). Tear GPx and GR levels correlated significantly but with low power with HR degree (r=0.299, p=0.004/ r=0.299, p=0.004).
Conclusion: Statistically significant elevation in tear GPx and GR activity and a tendency of GSH level increase was revealed, being attested, and a direct correlation between GPx and GR activity, as well as of their activity with the HR degree. In serum, the GSH level and the GPx activity did not change accurately, while the GR activity diminished significantly, the identified decrease being correlated with the HR degree. Abbreviations: HR = hypertensive retinopathy, HTN = hypertension, GSH = reduced glutathione, GPx = glutathione peroxidase, GR = glutathione reductase, GGR = gamma-glutamyl transferase, ROSs = reactive species of oxygen, OS = oxidative stress. ©Romanian Society of Ophthalmology.

Entities:  

Keywords:  antioxidant defense system; glutathione peroxidase; glutathione reductase; hypertensive retinopathy; reduced glutathione

Year:  2021        PMID: 33817433      PMCID: PMC7995505          DOI: 10.22336/rjo.2021.9

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  35 in total

Review 1.  Glutathione metabolism and its implications for health.

Authors:  Guoyao Wu; Yun-Zhong Fang; Sheng Yang; Joanne R Lupton; Nancy D Turner
Journal:  J Nutr       Date:  2004-03       Impact factor: 4.798

2.  Corcoran Lecture. Cardiovascular genomics and oxidative stress.

Authors:  Anna F Dominiczak; Delyth Graham; Martin W McBride; Nick J R Brain; Wai Kwong Lee; Fadi J Charchar; Maciej Tomaszewski; Christian Delles; Carlene A Hamilton
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

3.  Serum ferritin levels correlate with hypertensive retinopathy.

Authors:  Erkan Coban; Erhan Alkan; Seher Altuntas; Yusuf Akar
Journal:  Med Sci Monit       Date:  2010-02

4.  Immunohistochemical study of glutathione reductase in rat ocular tissues at different developmental stages.

Authors:  T Fujii; K Mori; Y Takahashi; N Taniguchi; A Tonosaki; H Yamashita; J Fujii
Journal:  Histochem J       Date:  2001-05

Review 5.  Oxidative-nitrosative stress in hypertension.

Authors:  Nelson Escobales; Maria J Crespo
Journal:  Curr Vasc Pharmacol       Date:  2005-07       Impact factor: 2.719

6.  Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS).

Authors:  Giovanni Corona; David M Lee; Gianni Forti; Daryl B O'Connor; Mario Maggi; Terence W O'Neill; Neil Pendleton; Gyorgy Bartfai; Steven Boonen; Felipe F Casanueva; Joseph D Finn; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E J Lean; Margus Punab; Alan J Silman; Dirk Vanderschueren; Frederick C W Wu
Journal:  J Sex Med       Date:  2009-11-19       Impact factor: 3.802

7.  The Keith-Wagener-Barker and Mitchell-Wong grading systems for hypertensive retinopathy: association with target organ damage in individuals below 55 years.

Authors:  Evaggelia K Aissopou; Miltiadis Papathanassiou; Efthimia G Nasothimiou; George D Konstantonis; Nikolaos Tentolouris; Panagiotis G Theodossiadis; Theodore G Papaioannou; Petros P Sfikakis; Athanasios D Protogerou
Journal:  J Hypertens       Date:  2015-11       Impact factor: 4.844

8.  Glutathione peroxidase enzyme activity in aging.

Authors:  Sara E Espinoza; Hongfei Guo; Neal Fedarko; Amy DeZern; Linda P Fried; Qian-Li Xue; Sean Leng; Brock Beamer; Jeremy D Walston
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-05       Impact factor: 6.053

9.  Glutathione level and glutathione-dependent enzyme activities in blood serum of patients with gastrointestinal tract tumors.

Authors:  Dorota Scibior; Michał Skrzycki; Małgorzata Podsiad; Hanna Czeczot
Journal:  Clin Biochem       Date:  2008-03-20       Impact factor: 3.281

10.  Glutathione-related antioxidant defense system in elderly patients treated for hypertension.

Authors:  J Rybka; D Kupczyk; K Kędziora-Kornatowska; J Motyl; J Czuczejko; K Szewczyk-Golec; M Kozakiewicz; H Pawluk; L A Carvalho; J Kędziora
Journal:  Cardiovasc Toxicol       Date:  2011-03       Impact factor: 3.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.